CVS Health Corp (NY:CVS)

86.43 -0.58 (-0.67%)

Official Closing Price Updated: 4:10 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway. ↗

October 01, 2026

Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.

Via The Motley Fool

CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

September 28, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Only a Handful of S&P 500 Stocks Can Match 10-Year Treasuries at 5%. Here's My Top Pick to Buy Now. ↗

September 26, 2026

Income investors now have a choice they haven't had to make in nearly two decades.

Via The Motley Fool

Topics Bonds Stocks

Q2 Earnings Outperformers: UnitedHealth (NYSE:UNH) And The Rest Of The Health Insurance Providers Stocks

September 23, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Health Insurance Providers Stocks Q2 Earnings Review: CVS Health (NYSE:CVS) Shines

September 17, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Should You Buy CVS Stock on the Dip? ↗

September 14, 2026

CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.

Via The Motley Fool

CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom ↗

September 10, 2026

CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on...

Via MarketBeat

Topics Earnings

Wall Street Loves CVS Health Stock Right Now. Should You? ↗

September 09, 2026

The stock is down about 13% from its 52-week high.

Via The Motley Fool

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky

September 08, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...

Via StockStory

Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks

September 07, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its pe...

Via StockStory

Topics Artificial Intelligence Economy Fraud

1 Healthcare Stock for Long-Term Investors and 2 We Ignore

September 04, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Via StockStory

Which S&P500 stocks are moving on Tuesday? ↗

September 01, 2026

Via Chartmill

Why CVS Stock Rallied Tuesday Morning ↗

September 01, 2026

Wall Street is warming to the prospects of the healthcare giant.

Via The Motley Fool

Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think ↗

August 29, 2026

The healthcare giant's shares have pulled back more than 12% over the past month.

Via The Motley Fool

Topics Earnings

Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers

August 27, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...

Via StockStory

Topics Artificial Intelligence Economy Fraud

2 Stocks That Could Capitalize on the GLP-1 Boom ↗

August 25, 2026

They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

Via The Motley Fool

3 Cash-Producing Stocks That Concern Us

August 25, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

3 Reasons to Sell CVS and 1 Stock to Buy Instead

August 25, 2026

CVS Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 12.8%. The stock now trades at $93.94, marking a 23.3%...

Via StockStory

Topics Stocks

Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks

August 23, 2026

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and it...

Via StockStory

Topics Economy

CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%. ↗

August 22, 2026

One of the pharmacy operator's segments is doing particularly well.

Via The Motley Fool

Health Insurance Providers Stocks Q2 Teardown: Clover Health (NASDAQ:CLOV) Vs The Rest

August 19, 2026

Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q2 health insurance providers earnings s...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Better Buy: CVS Stock or UnitedHealth Stock? ↗

August 18, 2026

These healthcare giants generate hundreds of billions in annual revenue.

Via The Motley Fool

Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks

August 18, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks

August 18, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers &...

Via StockStory

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now ↗

August 18, 2026

Novo Nordisk, CVS Health, and Bristol Myers are top dividend stocks that are trading at modest valuations.

Via The Motley Fool

3 S&P 500 Stocks with Open Questions

August 18, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

Spotting Winners: AMN Healthcare Services (NYSE:AMN) And Healthcare Providers & Services Stocks In Q2

August 16, 2026

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including AMN Healthcare Services (NYSE:AMN...

Via StockStory

Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

August 16, 2026

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnings season. Upfro...

Via StockStory

Topics Artificial Intelligence Economy Fraud

CVS Health (CVS) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Adjusted EPS surged 42.5% on margin recovery across all operating segments.

Via The Motley Fool

Topics Earnings Economy

The Top 5 Analyst Questions From CVS Health’s Q2 Earnings Call

August 12, 2026

CVS Health’s second quarter was marked by better-than-expected revenue and profit, but investor sentiment was dampened by rising concerns over sustainability...

Via StockStory

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.